Tau Networks in Psychotic Alzheimer's Disease

RecruitingOBSERVATIONAL
Enrollment

91

Participants

Timeline

Start Date

April 13, 2023

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2029

Conditions
Alzheimer DiseaseAlzheimer Disease With DelusionsAlzheimer Disease With Psychosis
Interventions
DIAGNOSTIC_TEST

[18F]-PI2620 PET scan

The PET scan will measure the regional distribution of tau aggregation in AD patients with and without psychosis compared to Cognitively Unimpaired Healthy participants with the PET radiotracer \[18F\]-PI2620.

Trial Locations (1)

11030

RECRUITING

The Feinstein Institutes for Medical Research, Manhasset

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Northwell Health

OTHER